A

ATP Clinical Research | Orange, CA

Research site

(Unclaimed)

Location

705 W La Veta Ave Suite 109, Orange, California, United States of America

Site insights

Top conditions

Top treatments

Aticaprant

Azetukalner

Iclepertin

Centanafadine

Psilocybin

VY7523-102

ANC-501

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 10 total trials

A Prospective Cohort Study to Assess Clinical Effectiveness of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of Schizophrenia

This study is open to people aged 18 years or older with schizophrenia. People can join the study if they are willing to use a smartphone app called...

Enrolling

Schizophrenia

Device: Digital therapeutic (CT-155)

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA2)

X-NOVA2 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of...

Enrolling

Major Depressive Disorder

Drug: Placebo

Drug: Azetukalner

An Open-Label Study of Azetukalner in Major Depressive Disorder (X-NOVA-OLE)

X-NOVA-OLE is a multicenter, open-label study to evaluate the long-term safety, tolerability, and efficacy of azetukalner as a monotherapy in adult p...

Invitation-only

Major Depressive Disorder

Drug: Azetukalner

Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD

Efficacy, Safety, and Tolerability of a single administration of COMP360 in participants with treatment-resistant depression (TRD)

Active, not recruiting

Treatment Resistant Depression

Drug: Psilocybin

VY7523-102: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study in Participants With Early Alzheimer's Disease

This study is to be conducted in participants with early Alzheimer's Disease to test VY7523, a new drug being researched for treatment of Alzheimer's...

Enrolling

Alzheimer's Disease (AD)

Drug: Placebo Comparator

Drug: VY7523